Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT) has reported earnings 27 times since Dec 20, 2019. The stock moves an average of ±8.21% the day after reporting, closing higher 48.1% of the time. Its largest post-earnings gain was +35.16% (May 20, 2026) and its largest decline was -37.99% (Jun 01, 2021). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
27
Avg Abs. Movement
±8.21%
Positive %
48.1%
Negative %
51.9%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | ☀ PRE | $30.35 | $36.25 | $35.52 | 860,551 | +35.16% | open_in_new |
| Feb 06, 2026 | ☀ PRE | $26.88 | $27.34 | $27.05 | 3,313,300 | +12.43% | open_in_new |
| Nov 10, 2025 | ☀ PRE | $22.76 | $23.80 | $23.37 | 1,728,600 | +0.09% | open_in_new |
| Aug 11, 2025 | ☀ PRE | $15.50 | $15.60 | $14.76 | 1,687,800 | -4.53% | open_in_new |
| May 29, 2025 | ☀ PRE | $14.75 | $15.22 | $14.89 | 1,643,200 | +5.6% | open_in_new |
| Feb 06, 2025 | ☀ PRE | $23.00 | $23.11 | $20.36 | 2,758,700 | -9.55% | open_in_new |
| Nov 07, 2024 | ☀ PRE | $31.26 | $31.66 | $29.93 | 746,500 | -4.74% | open_in_new |
| Aug 06, 2024 | ☽ POST | $26.95 | $28.04 | $27.85 | 818,200 | -3.12% | open_in_new |
| May 29, 2024 | ☽ POST | $31.21 | $31.81 | $29.57 | 2,784,700 | -10.69% | open_in_new |
| Feb 12, 2024 | ☀ PRE | $33.95 | $36.75 | $36.69 | 1,402,100 | +3.35% | open_in_new |
| Nov 09, 2023 | ☀ PRE | $32.66 | $33.27 | $31.31 | 1,690,700 | -6.23% | open_in_new |
| Aug 10, 2023 | ☀ PRE | $20.82 | $22.48 | $22.32 | 1,143,900 | +6.69% | open_in_new |
| May 22, 2023 | ☀ PRE | $21.37 | $24.18 | $23.75 | 3,078,000 | +11.98% | open_in_new |
| Feb 03, 2023 | ☀ PRE | $16.40 | $19.09 | $17.75 | 1,249,300 | -2.95% | open_in_new |
| Nov 04, 2022 | ☀ PRE | $11.60 | $12.10 | $12.05 | 674,200 | +1.09% | open_in_new |
| Aug 05, 2022 | ☀ PRE | $4.36 | $4.76 | $4.76 | 384,100 | +8.68% | open_in_new |
| Jun 08, 2022 | ☀ PRE | $4.39 | $4.45 | $3.92 | 226,100 | -8.2% | open_in_new |
| Feb 04, 2022 | ☀ PRE | $6.08 | $6.17 | $5.91 | 2,669,200 | -1.83% | open_in_new |
| Nov 05, 2021 | ☀ PRE | $8.63 | $9.07 | $8.58 | 758,200 | -1.61% | open_in_new |
| Aug 09, 2021 | ☀ PRE | $7.72 | $8.02 | $7.78 | 1,018,400 | +0.39% | open_in_new |
| Jun 01, 2021 | ☀ PRE | $11.36 | $13.00 | $9.40 | 16,909,700 | -37.99% | open_in_new |
| Feb 16, 2021 | ☀ PRE | $22.40 | $22.40 | $16.17 | 6,767,700 | -27.19% | open_in_new |
| Nov 12, 2020 | ☀ PRE | $48.78 | $50.68 | $49.14 | 383,800 | +0.02% | open_in_new |
| Aug 12, 2020 | ☽ POST | $26.97 | $28.04 | $26.93 | 143,500 | +3.08% | open_in_new |
| Jun 29, 2020 | ☀ PRE | $27.41 | $27.73 | $25.45 | 670,000 | -7.01% | open_in_new |
| Feb 14, 2020 | ☀ PRE | $14.62 | $15.70 | $15.44 | 40,700 | +6.41% | open_in_new |
| Dec 20, 2019 | ☽ POST | $15.53 | $16.13 | $15.96 | 119,000 | -1.1% | open_in_new |
Earnings Count
27
Total earnings in dataset
Avg Abs. Movement
±8.21%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260529 | open_in_new SEC.gov |
| 144 | 20260528 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 10-K | 20260520 | open_in_new SEC.gov |
| 144 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 8-K | 20260520 | open_in_new SEC.gov |
| 144 | 20260501 | open_in_new SEC.gov |
| 4 | 20260501 | open_in_new SEC.gov |
| 4 | 20260424 | open_in_new SEC.gov |
Frequently asked about IMVT earnings
When does Immunovant, Inc. report earnings next? expand_more
Immunovant, Inc. (IMVT)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does IMVT stock move after earnings? expand_more
Over 27 reports, IMVT has moved an average of ±8.21% the session after earnings, closing higher 48.1% of the time.
What was IMVT's biggest post-earnings move? expand_more
IMVT's largest post-earnings gain on record was +35.16% on May 20, 2026, and its largest decline was -37.99% on Jun 01, 2021.
Where can I find Immunovant, Inc.'s SEC filings? expand_more
All of Immunovant, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right